AIM
AMPH icon

Acrospire Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Acrospire Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,451
Closed -$26K – 68
2017
Q2 		$26K Sell
1,451
-1,000
-41% -$15.9K 0.02% 1361
2017
Q1 		$36K Sell
2,451
-100
-4% -$1.57K 0.03% 1219
2016
Q4 		$47K Sell
2,551
-3,140
-55% -$61.1K 0.02% 1423
2016
Q3 		$108K Sell
5,691
-1,100
-16% -$20K 0.07% 494
2016
Q2 		$109K Buy
6,791
+2,479
+57% +$35K 0.08% 373
2016
Q1 		$52K Buy
+4,312
New +$50.8K 0.04% 903

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Acrospire Investment Management's AMPH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2017, closing a stake of 1,451 shares — an estimated $26K sold.

Acrospire Investment Management first reported a position in AMPH in Q1 2016 and held it in 6 quarters. The position peaked at $109K in Q2 2016. 104 funds tracked by Wall St. Rank hold AMPH as of Q3 2017.

  • Acrospire Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,451 Amphastar Pharmaceuticals shares in Q3 2017, an estimated $26K.
  • Acrospire Investment Management first reported a position in Amphastar Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Amphastar Pharmaceuticals position peaked at $109K in Q2 2016.
  • 104 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.